TFOS DEWS II definition and classification report JP Craig, KK Nichols, EK Akpek, B Caffery, HS Dua, CK Joo, Z Liu, ... The ocular surface 15 (3), 276-283, 2017 | 2167 | 2017 |
2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: a consensus and data‐driven methodology … CH Shiboski, SC Shiboski, R Seror, LA Criswell, M Labetoulle, ... Arthritis & rheumatology 69 (1), 35-45, 2017 | 1830 | 2017 |
American College of Rheumatology classification criteria for Sjögren's syndrome: a data‐driven, expert consensus approach in the Sjögren's International Collaborative Clinical … SC Shiboski, CH Shiboski, LA Criswell, AN Baer, S Challacombe, ... Arthritis care & research 64 (4), 475-487, 2012 | 1443 | 2012 |
Artificial Cornea and Method of Making Same EK Akpek, GV Balaji, PJ Fischer, TB Schmiedel, A Singh US Patent App. 11/735,179, 2008 | 355 | 2008 |
Ocular rosacea: patient characteristics and follow-up EK Akpek, A Merchant, V Pinar, CS Foster Ophthalmology 104 (11), 1863-1867, 1997 | 306 | 1997 |
Conjunctivitis in dupilumab clinical trials B Akinlade, E Guttman‐Yassky, M Bruin‐Weller, EL Simpson, A Blauvelt, ... British Journal of Dermatology 181 (3), 459-473, 2019 | 285 | 2019 |
Autologous serum eye drops for dry eye Q Pan, A Angelina, M Marrone, WJ Stark, EK Akpek Cochrane Database of Systematic Reviews, 2017 | 268 | 2017 |
Evaluation of patients with scleritis for systemic disease EK Akpek, JE Thorne, FA Qazi, DV Do, DA Jabs Ophthalmology 111 (3), 501-506, 2004 | 259 | 2004 |
Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes EK Akpek, I Ahmed, FH Hochberg, M Soheilian, TP Dryja, FA Jakobiec, ... Ophthalmology 106 (9), 1805-1810, 1999 | 244 | 1999 |
TFOS DEWS II Introduction JD Nelson, JP Craig, EK Akpek, DT Azar, C Belmonte, AJ Bron, ... Ocular Surface, 2017 | 233 | 2017 |
Dry eye: an inflammatory ocular disease M Hessen, EK Akpek Journal of ophthalmic & vision research 9 (2), 240, 2014 | 219 | 2014 |
A randomized trial of topical cyclosporin 0.05% in topical steroid–resistant atopic keratoconjunctivitis EK Akpek, JK Dart, S Watson, W Christen, D Dursun, S Yoo, TP O'Brien, ... Ophthalmology 111 (3), 476-482, 2004 | 207 | 2004 |
Interventions for chronic blepharitis K Lindsley, S Matsumura, E Hatef, EK Akpek Cochrane database of systematic reviews, 2012 | 188 | 2012 |
Clinical review: topical ophthalmic use of cyclosporin A CA Utine, M Stern, EK Akpek Ocular immunology and inflammation 18 (5), 352-361, 2010 | 173 | 2010 |
Immune defense at the ocular surface EK Akpek, JD Gottsch Eye 17 (8), 949-956, 2003 | 168 | 2003 |
Acute and chronic ophthalmic involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis–a comprehensive review and guide to therapy. II. Ophthalmic disease S Kohanim, S Palioura, HN Saeed, EK Akpek, G Amescua, S Basu, ... The ocular surface 14 (2), 168-188, 2016 | 164 | 2016 |
Evaluation of patients with dry eye for presence of underlying Sjögren’s syndrome EK Akpek, A Klimava, JE Thorne, D Martin, K Lekhanont, A Ostrovsky Cornea 28 (5), 493, 2009 | 150 | 2009 |
Topical ciclosporin in the treatment of ocular surface disorders S Tatlipinar, EK Akpek British Journal of Ophthalmology 89 (10), 1363-1367, 2005 | 145 | 2005 |
Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study EK Akpek, M Harissi-Dagher, R Petrarca, SI Butrus, R Pineda II, ... American journal of ophthalmology 144 (2), 227-231. e1, 2007 | 137 | 2007 |
Long-term outcomes of Boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort D Srikumaran, B Munoz, AJ Aldave, JV Aquavella, SB Hannush, ... Ophthalmology 121 (11), 2159-2164, 2014 | 135 | 2014 |